Tech Company Financing Transactions
Renovis Funding Round
On 8/11/2003, Renovis secured $45 million in Series E funding from Easton Capital, Alta Partners and Flagship Pioneering.
Transaction Overview
Company Name
Announced On
8/11/2003
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series E
Investors
Easton Capital (Lead Investor) (John Friedman)
Proceeds Purpose
Additionally, the Company will use the funds raised in this financing to expand its clinical pipeline with new development candidates from its preclinical programs
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Two Corporate Drive
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Not Recorded
Overview
Renovis, Inc., a biopharmaceutical company focused on the discovery and development of drugs to treat neurological diseases and disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Corey Godman
VP - Human Resources
Marlene Perry
VP - R & D
Michael Kelly
Browse more venture capital transactions:
Prev: 8/8/2003: LightSand Communications venture capital transaction
Next: 8/12/2003: Fieldglass venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs